{"title":"Prostacyclin and heparin during haemodialysis: comparative effects.","authors":"M Camici, L Evangelisti","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Haemodialysis was performed using heparin (dialysis I: heparin regimen 1, 2000 U/h) in ten patients. These subjects were then given an infusion of prostacyclin, in the form of epoprostenol sodium salt (dialysis II: prostacyclin, 5 ng X kg-1 X min-1), followed by an infusion of prostacyclin and heparin (dialysis III: heparin regimen 2,500 U/h). Absolute platelet count, in vitro platelet aggregation and plasma beta-thromboglobulin decreased during prostacyclin infusion. Haemodialysis neutropenia was improved by prostacyclin. The membrane sieving coefficient factor and ultrafiltration volume were not improved by prostacyclin alone (dialysis II). Prostacyclin together with heparin (dialysis III) showed, 60 minutes after the start, an unchanged sieving coefficient factor compared with that of heparin alone, while the ultrafiltration volume significantly (P less than 0.001) improved. The results of this study confirm those of earlier studies and suggest that prostaglandin I2 together with low-dose heparin improve the biocompatibility and efficiency of dialysis treatment.</p>","PeriodicalId":77869,"journal":{"name":"Life support systems : the journal of the European Society for Artificial Organs","volume":"4 3","pages":"205-9"},"PeriodicalIF":0.0000,"publicationDate":"1986-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life support systems : the journal of the European Society for Artificial Organs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Haemodialysis was performed using heparin (dialysis I: heparin regimen 1, 2000 U/h) in ten patients. These subjects were then given an infusion of prostacyclin, in the form of epoprostenol sodium salt (dialysis II: prostacyclin, 5 ng X kg-1 X min-1), followed by an infusion of prostacyclin and heparin (dialysis III: heparin regimen 2,500 U/h). Absolute platelet count, in vitro platelet aggregation and plasma beta-thromboglobulin decreased during prostacyclin infusion. Haemodialysis neutropenia was improved by prostacyclin. The membrane sieving coefficient factor and ultrafiltration volume were not improved by prostacyclin alone (dialysis II). Prostacyclin together with heparin (dialysis III) showed, 60 minutes after the start, an unchanged sieving coefficient factor compared with that of heparin alone, while the ultrafiltration volume significantly (P less than 0.001) improved. The results of this study confirm those of earlier studies and suggest that prostaglandin I2 together with low-dose heparin improve the biocompatibility and efficiency of dialysis treatment.
10例患者采用肝素进行血液透析(透析I:肝素方案1,2000 U/h)。这些受试者随后输注前列环素,以环氧前列醇钠盐的形式(透析II:前列环素,5 ng X kg-1 X min-1),随后输注前列环素和肝素(透析III:肝素方案2500 U/h)。前列环素输注期间血小板绝对计数、体外血小板聚集和血浆β -血栓球蛋白下降。前列环素可改善血液透析中性粒细胞减少症。单独使用前列环素(透析II)对膜筛选系数因子和超滤体积没有改善,与单独使用肝素(透析III)相比,前列环素联合使用肝素(透析III)在启动后60分钟的筛选系数因子没有变化,但超滤体积有显著改善(P < 0.001)。本研究结果证实了早期的研究结果,提示前列腺素I2联合低剂量肝素可提高透析治疗的生物相容性和效率。